Development of [ 177 Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma.

Jianhao ChenYizhen PangXiyi LiaoYangfan ZhouQicong LuoHua WuChangjing ZuoJingjing ZhangQin LinXiaoyuan ChenLiang ZhaoHaojun Chen

Published in: European journal of nuclear medicine and molecular imaging (2024)

Lu]Lu-LNC1010 is a promising treatment for advanced NPC, extending the clinical scope of PRRT beyond neuroendocrine tumours.

Keyphrases